Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products
Authors
Keywords
Statin, Dietary Supplement, Prescription Product, Icosapent Ethyl, Residual Cardiovascular Risk
Journal
American Journal of Cardiovascular Drugs
Volume 16, Issue 4, Pages 229-239
Publisher
Springer Nature
Online
2016-04-30
DOI
10.1007/s40256-016-0170-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardioprotective mechanism of omega-3 polyunsaturated fatty acids
- (2016) Jin Endo et al. Journal of Cardiology
- Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease
- (2016) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Triglyceride-Rich Lipoproteins and Coronary Artery Disease Risk: New Insights From Human Genetics
- (2015) S. A. Khetarpal et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis
- (2015) Kenneth M. Borow et al. ATHEROSCLEROSIS
- Proof That Lower Is Better — LDL Cholesterol and IMPROVE-IT
- (2015) John A. Jarcho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
- (2015) Jennifer G. Robinson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
- (2015) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fish oil supplements in New Zealand are highly oxidised and do not meet label content of n-3 PUFA
- (2015) Benjamin B. Albert et al. Scientific Reports
- Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheroma
- (2014) Ryo Nishio et al. ATHEROSCLEROSIS
- Residual macrovascular risk in 2013: what have we learned?
- (2014) Jean-Charles Fruchart et al. Cardiovascular Diabetology
- Triglycerides on the rise: should we swap seats on the seesaw?
- (2014) Peter Libby EUROPEAN HEART JOURNAL
- Combination Eicosapentaenoic Acid and Statin Treatment Reversed Endothelial Dysfunction in HUVECs Exposed to Oxidized LDL
- (2014) R. Preston Mason et al. Journal of Clinical Lipidology
- A comparison of actual versus stated label amounts of EPA and DHA in commercial omega-3 dietary supplements in the United States
- (2014) Alison C Kleiner et al. JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
- Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
- (2014) Anders Berg Jørgensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hazards of Hindsight — Monitoring the Safety of Nutritional Supplements
- (2014) Pieter A. Cohen NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Eicosapentaenoic Acid Combined with Optimal Statin Therapy Improves Endothelial Dysfunction in Patients with Coronary Artery Disease
- (2013) Kentaro Toyama et al. CARDIOVASCULAR DRUGS AND THERAPY
- A Highly Bioavailable Omega-3 Free Fatty Acid Formulation Improves the Cardiovascular Risk Profile in High-Risk, Statin-Treated Patients With Residual Hypertriglyceridemia (the ESPRIT Trial)
- (2013) Kevin C. Maki et al. CLINICAL THERAPEUTICS
- Efficacy and safety of TAK-085 compared with eicosapentaenoic acid in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: The omega-3 fatty acids randomized double-blind (ORD) study
- (2013) Ichiro Tatsuno et al. Journal of Clinical Lipidology
- Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial
- (2013) John J.P. Kastelein et al. Journal of Clinical Lipidology
- An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report
- (2013) Scott M. Grundy et al. Journal of Clinical Lipidology
- n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Distinct regulation of plasma LDL cholesterol by eicosapentaenoic acid and docosahexaenoic acid in high fat diet-fed hamsters: Participation of cholesterol ester transfer protein and LDL receptor
- (2013) Takayuki Ishida et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)
- (2012) Christie M. Ballantyne et al. AMERICAN JOURNAL OF CARDIOLOGY
- α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis
- (2012) An Pan et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Dietary sources of omega 3 fatty acids: public health risks and benefits
- (2012) J. A. Tur et al. BRITISH JOURNAL OF NUTRITION
- Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia
- (2012) N. Satoh-Asahara et al. DIABETES CARE
- Administration of highly purified eicosapentaenoic acid to statin-treated diabetic patients further improves vascular function
- (2012) Junko Sasaki et al. ENDOCRINE JOURNAL
- Omega-3 fatty acid supplementation and cardiovascular disease
- (2012) Donald B. Jump et al. JOURNAL OF LIPID RESEARCH
- Effects of fatty acids on endothelial cells: inflammation and monocyte adhesion
- (2012) S. Marlene Grenon et al. JOURNAL OF SURGICAL RESEARCH
- THE IMPACT OF A PURE-EPA OMEGA-3 FATTY ACID ON CORONARY PLAQUE STABILIZATION; A PLAQUE COMPONENT ANALYSIS WITH 64-SLICE MULTI-DETECTOR ROW COMPUTED TOMOGRAPHY
- (2012) Yoshiaki Shintani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Quality analysis of commercial fish oil preparations
- (2012) Jenna C Sullivan Ritter et al. JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
- n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)
- (2011) Harold E. Bays et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis
- (2011) Melissa Y. Wei et al. Current Atherosclerosis Reports
- Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: A review
- (2011) Terry A. Jacobson et al. Journal of Clinical Lipidology
- A Meta-Analysis Shows That Docosahexaenoic Acid from Algal Oil Reduces Serum Triglycerides and Increases HDL-Cholesterol and LDL-Cholesterol in Persons without Coronary Heart Disease
- (2011) Adam M. Bernstein et al. JOURNAL OF NUTRITION
- Modulation of blood cell gene expression by DHA supplementation in hypertriglyceridemic men
- (2011) Kevin Dawson et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Long Chain Omega-3 Dietary Supplements: A Review of the National Library of Medicine Herbal Supplement Database
- (2011) Atanaz Zargar et al. Metabolic Syndrome and Related Disorders
- Determination of lipid oxidation products in vegetable oils and marine omega-3 supplements
- (2011) Bente Lise Halvorsen et al. Food & Nutrition Research
- Eicosapentaenoic acid (EPA) from highly concentrated n−3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability
- (2010) Abbie L. Cawood et al. ATHEROSCLEROSIS
- Omega-3 fatty acid supplementation improves vascular function and reduces inflammation in obese adolescents
- (2010) Frida Dangardt et al. ATHEROSCLEROSIS
- Fish Oil for the Treatment of Cardiovascular Disease
- (2010) Daniel Weitz et al. Cardiology in Review
- OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial Infarction
- (2010) Bernhard Rauch et al. CIRCULATION
- Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids
- (2010) Yuriko Adkins et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Effects of Polyunsaturated Omega-3 Fatty Acids on Responsiveness to Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention
- (2010) Grzegorz Gajos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
- (2010) Daan Kromhout et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies
- (2009) Roland Klingenberg et al. EUROPEAN HEART JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started